Animal studies suggest that transgenic overexpression of human RBP4 or injection of recombinant RBP4 in wild-type mice causes insulin resistance; on the contrary, genetic deletion of RBP4 enhances insulin sensitivity [6]. The gene discussed is RBP4; the disease is Insulin resistance.